Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	FONAR	IRIDEX	BioSig Technologies	ENDRA Life Sciences	Soleno Therapeutics
Symbol	NASDAQ:FONR	NASDAQ:IRIX	NASDAQ:BSGM	NASDAQ:NDRA	NASDAQ:SLNO
Price Information
Current Price	$17.19	$7.80	$3.21	$2.17	$1.11
52 Week Range	N/A	Buy	N/A	N/A	Buy
MarketRank™
Overall Score	1.1	0.9	0.5	0.6	1.9
Analysis Score	0.0	1.5	0.0	0.0	3.5
Community Score	2.8	2.5	2.7	2.3	2.8
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.8	0.0	0.0	0.0	2.5
Earnings & Valuation Score	1.9	0.6	0.0	0.6	0.6
Analyst Ratings
Consensus Recommendation	N/A	Buy	N/A	N/A	Buy
Consensus Price Target	N/A	$6.50	N/A	N/A	$8.67
% Upside from Price Target	N/A	-16.67% downside	N/A	N/A	680.78% upside
Trade Information
Market Cap	$112.66 million	$121.88 million	$103.18 million	$90.36 million	$88.49 million
Beta	1.07	1.2	1.83	1.6	0.71
Average Volume	34,812	332,111	312,433	2,705,955	1,586,255
Sales & Book Value
Annual Revenue	$85.69 million	$43.45 million	N/A	$10,000.00	N/A
Price / Sales	1.31	2.81	N/A	9,035.88	N/A
Cashflow	$1.82 per share	N/A	N/A	N/A	N/A
Price / Cash	9.44	N/A	N/A	N/A	N/A
Book Value	$19.58 per share	$1.65 per share	$0.53 per share	$0.57 per share	$0.33 per share
Price / Book	0.88	4.73	N/A	3.81	N/A
Profitability
Net Income	$8.24 million	$-8,810,000.00	$-34,060,000.00	$-13,310,000.00	$-30,770,000.00
EPS	N/A	($0.64)	N/A	($2.34)	($0.70)
Trailing P/E Ratio	16.22	N/A	0.00	N/A	N/A
Forward P/E Ratio	∞	N/A	∞	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	8.28%	-21.54%	N/A	N/A	N/A
Return on Equity (ROE)	5.57%	-38.60%	-244.64%	-492.76%	-88.69%
Return on Assets (ROA)	3.99%	-24.99%	-213.88%	-288.58%	-51.63%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.01%	0.06%	N/A	0.10%	N/A
Current Ratio	5.32%	2.77%	6.83%	3.42%	7.06%
Quick Ratio	5.22%	2.01%	6.67%	3.19%	7.06%
Ownership Information
Institutional Ownership Percentage	62.09%	32.61%	18.33%	2.84%	55.38%
Insider Ownership Percentage	8.58%	2.00%	19.49%	9.60%	74.90%
Miscellaneous
Employees	424	89	49	18	17
Shares Outstanding	6.55 million	15.63 million	32.14 million	41.64 million	79.72 million
Next Earnings Date	5/10/2021 (Estimated)	5/11/2021 (Confirmed)	5/10/2021 (Estimated)	5/17/2021 (Confirmed)	8/9/2021 (Estimated)
Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Source	Headline
	Soleno Therapeutics (NASDAQ:SLNO) Releases Earnings Results, Misses Estimates By $0.03 EPS americanbankingnews.com - May 6 at 9:48 PM
	Soleno Therapeutics, Inc. (NASDAQ:SLNO) Down Almost -13.93% in 1 Month, But Long Term Looking Good marketingsentinel.com - May 6 at 1:19 PM
	Soleno Therapeutics, Inc. (NASDAQ:SLNO) Expected to Post Earnings of -$0.04 Per Share americanbankingnews.com - May 5 at 11:12 PM
	Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results finance.yahoo.com - May 5 at 5:18 PM
	Soleno Therapeutics' DCCR Treatment Shows Improvement In Multiple Behavioral Domains In Prader-Willi Syndrome Patients finance.yahoo.com - May 4 at 3:38 PM
	Soleno Therapeutics Announces Presentation of Positive Behavioral Data from Ongoing Extension Study of DCCR for Treatment of Prader-Willi Syndrome finance.yahoo.com - May 4 at 10:37 AM
	After A 5.13% Rise In The Last Week, Does Soleno Therapeutics, Inc. (NASDAQ:SLNO) Still Make Sense To Buy? marketingsentinel.com - April 30 at 2:57 PM
	Critical Review: Micron Solutions (OTCMKTS:MICR) vs. Soleno Therapeutics (NASDAQ:SLNO) americanbankingnews.com - April 30 at 4:30 AM
	Soleno Therapeutics, Inc. (NASDAQ:SLNO): Here’s What’s Really Going On stocksregister.com - April 28 at 2:13 PM
	Soleno Therapeutics, Inc. (NASDAQ:SLNO) Expected to Announce Earnings of -$0.04 Per Share americanbankingnews.com - April 18 at 6:18 PM
	Soleno Therapeutics, Inc. (NASDAQ:SLNO) Sees Significant Increase in Short Interest americanbankingnews.com - April 18 at 4:44 AM
	Soleno Therapeutics Participates in Prader-Willi Syndrome (PWS) DCCR Town Hall finance.yahoo.com - April 15 at 12:21 AM
	Soleno Therapeutics, Inc. (SLNO) has great growth outlook for 2021 marketingsentinel.com - April 12 at 3:02 PM
	Soleno Therapeutics (SLNO) Enters Oversold Territory finance.yahoo.com - March 30 at 9:01 AM
	Here's Why We're Watching Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation finance.yahoo.com - March 29 at 5:55 PM
	Market Analysts see Soleno Therapeutics Inc. [SLNO] gaining to $8. Time to buy? dbtnews.com - March 26 at 6:34 PM
	SLNO Jul 2021 4.000 call au.finance.yahoo.com - March 13 at 9:23 AM
	Soleno to Participate in the 31st Annual Oppenheimer Healthcare Conference Nasdaq:SLNO compsmag.com - March 9 at 5:38 PM
	Soleno to Participate in the 31st Annual Oppenheimer Healthcare Conference finance.yahoo.com - March 9 at 5:38 PM
	Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Contact the Firm finance.yahoo.com - March 9 at 12:38 PM
	Soleno Therapeutics (SLNO) Is in Oversold Territory: What's Next? msn.com - March 9 at 7:38 AM
	Why Soleno Therapeutics Is Trading Lower Today msn.com - March 8 at 12:51 PM
	Soleno Shares Are Trading Lower After FDA Demands Additional Study For DCCR Program In Prader-Willi Syndrome finance.yahoo.com - March 8 at 12:51 PM
	Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results - 03.03.2021 wallstreet-online.de - March 5 at 8:17 AM
	Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 ... apnews.com - March 4 at 7:13 AM

Date	Company	Brokerage	Action
3/9/2021	IRIDEX	Roth Capital	Boost Price Target
5/12/2020	IRIDEX	Stifel Nicolaus	Lower Price Target
2/20/2019	BioSig Technologies	Laidlaw	Set Price Target
11/18/2019	ENDRA Life Sciences	HC Wainwright	Reiterated Rating
6/13/2019	ENDRA Life Sciences	Dougherty & Co	Initiated Coverage
5/20/2019	ENDRA Life Sciences	Lake Street Capital	Initiated Coverage
3/3/2021	Soleno Therapeutics	Oppenheimer	Reiterated Rating
9/29/2020	Soleno Therapeutics	Guggenheim	Initiated Coverage
1/10/2020	Soleno Therapeutics	Craig Hallum	Initiated Coverage
12/20/2018	Soleno Therapeutics	Maxim Group	Set Price Target
5/16/2018	Soleno Therapeutics	Noble Financial	Set Price Target

(Data available from 5/9/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources